In non-small-cell lung cancer, upregulation of LINC00665 confers gefitinib resistance by increasing EGFR expression and activating downstream AKT signaling, thus antagonizes gefitinib induced cell apoptosis and proliferation arrest11. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.